12 Health Care Stocks Moving In Thursday's Pre-Market Session

GainersProcessa Pharma (NASDAQ:PCSA) shares moved upwards by 31.2% to $2.12 during Thursday's pre-market session. The company's market cap stands at $6.0 million. Cyclacel Pharmaceuticals (NASDAQ:CYCC

BenzingaApr 25 08:06 ET

Express News | Can-Fite Biopharma Announced It Published An Article In The Experimental And Therapeutic Medicine Journal, "Long-term Complete Response To Namodenoson In Liver Cancer With Child-Pugh B Cirrhosis

BenzingaApr 25 07:28 ET

Can-Fite: Scientific Article Published by KOL Presents Namodenoson as a Promising Drug Candidate to Treat Advanced Liver Cancer and MASH

A pivotal Phase III trial for advanced liver cancer, approved by FDA & EMA and a MASH Phase IIb are enrolling patients Can-Fite BioPharma Ltd. (NYSE:CANF) (TASE: CANF), a biotechnology company advancing a pipeline

BusinesswireApr 15 07:00 ET

Can-Fite: Submits FDA With an IND Application to Conduct Phase IIb Clinical Trial of Namodenoson in MASH Patients

Namodenoson demonstrated anti-fibrosis, anti-steatosis and anti-inflammatory effects in former Phase IIa study Patient enrolment for Phase IIb study is ongoing in Europe and Israel Can-Fite BioPharma Ltd.

BusinesswireApr 3 07:00 ET

Can-Fite BioPharma, Ltd. to Present at the LD Micro Invitational XIV

Yahoo FinanceApr 1 07:00 ET

US Investors Beware: Tax Complications for Can-Fite BioPharma Shareholders

TipRanksMar 29 02:00 ET